These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21364208)

  • 1. The beginning of icodextrin.
    Mistry CD
    Perit Dial Int; 2011 Mar; 31 Suppl 2():S49-52. PubMed ID: 21364208
    [No Abstract]   [Full Text] [Related]  

  • 2. Future clinical research with icodextrin-containing solutions.
    Shockley TR; Wang T; Lindholm B
    Perit Dial Int; 1997; 17 Suppl 2():S70-4. PubMed ID: 9163802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peritoneal transport with icodextrin solution.
    Heimbürger O
    Contrib Nephrol; 2006; 150():97-103. PubMed ID: 16720998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Icodextrin provides long dwell peritoneal dialysis and maintenance of intraperitoneal volume.
    Peers E; Gokal R
    Artif Organs; 1998 Jan; 22(1):8-12. PubMed ID: 9456219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Icodextrin: overview of clinical experience.
    Peers E; Gokal R
    Perit Dial Int; 1997; 17(1):22-6. PubMed ID: 9068018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Future of icodextrin as an osmotic agent in peritoneal dialysis.
    Pecoits-Filho R; Mujais S; Lindholm B
    Kidney Int Suppl; 2002 Oct; (81):S80-7. PubMed ID: 12230485
    [No Abstract]   [Full Text] [Related]  

  • 7. Icodextrin metabolites in peritoneal dialysis.
    García-López E; Lindholm B
    Perit Dial Int; 2009; 29(4):370-6. PubMed ID: 19602601
    [No Abstract]   [Full Text] [Related]  

  • 8. [History of nephrology in the past 100 years: Dialysis].
    Maeda K
    Nihon Naika Gakkai Zasshi; 2002 May; 91(5):1413-6. PubMed ID: 12082725
    [No Abstract]   [Full Text] [Related]  

  • 9. Icodextrin: a review of its use in peritoneal dialysis.
    Frampton JE; Plosker GL
    Drugs; 2003; 63(19):2079-105. PubMed ID: 12962523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Icodextrin: an alternative peritoneal dialysis fluid.
    Chhabra D; Nash K
    Expert Opin Drug Metab Toxicol; 2008 Nov; 4(11):1455-64. PubMed ID: 18950286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposure to the peptidoglycan contaminant in icodextrin may cause sensitization of the patient maintained on peritoneal dialysis.
    Povlsen JV; Ivarsen P; Jørgensen KA; Madsen S
    Perit Dial Int; 2003; 23(5):509-10. PubMed ID: 14604210
    [No Abstract]   [Full Text] [Related]  

  • 12. Amadori albumin and advanced glycation end-product formation in peritoneal dialysis using icodextrin.
    Posthuma N; ter Wee PM; Niessen H; Donker AJ; Verbrugh HA; Schalkwijk CG
    Perit Dial Int; 2001; 21(1):43-51. PubMed ID: 11280495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does peritoneal dialysis predispose a diabetic patient to icodextrin-induced peritonitis?
    Fiedler R; Schneider I; Buchmann J; Osten B; Langer T
    Nephrol Dial Transplant; 2002 Sep; 17(9):1708-9. PubMed ID: 12198234
    [No Abstract]   [Full Text] [Related]  

  • 14. [Icodextrin: What arguments for and against its use as an osmotic agent in peritoneal dialysis].
    Savenkoff B; Flechon-Meibody F; Goffin É
    Nephrol Ther; 2018 Jun; 14(4):201-206. PubMed ID: 29291942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aseptic peritonitis and icodextrin.
    Goffin E
    Perit Dial Int; 2006; 26(3):314-6. PubMed ID: 16722022
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of icodextrin-based dialysis solution on peritoneal leptin clearance.
    Opatrná S; Opatrný K; Racek J; Sefrna F
    Perit Dial Int; 2003; 23(1):89-91. PubMed ID: 12691516
    [No Abstract]   [Full Text] [Related]  

  • 17. Advanced glycosylation end-products in diabetic rats on peritoneal dialysis using various solutions.
    Lee JH; Reddy DK; Saran R; Moore HL; Twardowski ZJ; Nolph KD; Khanna R
    Perit Dial Int; 2000; 20(6):643-51. PubMed ID: 11216553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Icodextrin metabolism and alpha-amylase activity in nonuremic rats undergoing chronic peritoneal dialysis.
    García-López E; Pawlaczyk K; Anderstam B; Qureshi AR; Kuzlan-Pawlaczyk M; Heimbürger O; Werynski A; Lindholm B
    Perit Dial Int; 2007; 27(4):415-23. PubMed ID: 17602150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of icodextrin and glucose solutions for long dwell exchange in peritoneal dialysis: a meta-analysis of randomized controlled trials.
    Qi H; Xu C; Yan H; Ma J
    Perit Dial Int; 2011; 31(2):179-88. PubMed ID: 21119069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of icodextrin during nocturnal automated peritoneal dialysis allows sustained ultrafiltration while reducing the peritoneal glucose load: a randomized crossover study.
    Rodríguez-Carmona A; Pérez Fontán M; García López E; García Falcón T; Díaz Cambre H
    Perit Dial Int; 2007; 27(3):260-6. PubMed ID: 17468473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.